Potential	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
among	O
prescriptions	O
for	O
elderly	O
patients	O
in	O
primary	O
health	I:C0033137
care	I:C0033137
.	O

Potential	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
among	O
prescriptions	B:C0033080
for	O
elderly	O
patients	O
in	O
primary	O
health	I:C0033137
care	I:C0033137
.	O

Potential	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
among	O
prescriptions	O
for	O
elderly	B:C0001792
patients	O
in	O
primary	O
health	I:C0033137
care	I:C0033137
.	O

Potential	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
among	O
prescriptions	O
for	O
elderly	O
patients	O
in	O
primary	B:C0033137
health	I:C0033137
care	I:C0033137
.	O

Elderly	B:C0001792
patients	O
are	O
at	O
high	O
risk	I:C0332167
from	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
(	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
)	O
.	O

Elderly	O
patients	O
are	O
at	O
high	B:C0332167
risk	I:C0332167
from	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
(	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
)	O
.	O

Elderly	O
patients	O
are	O
at	O
high	O
risk	I:C0332167
from	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
(	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
)	O
.	O

Elderly	O
patients	O
are	O
at	O
high	O
risk	I:C0332167
from	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
(	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
)	O
.	O

This	O
study	B:C2603343
evaluates	O
the	O
potential	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
in	O
Turkish	O
elderly	O
patients	O
at	O
a	O
primary	O
health	I:C0033137
care	I:C0033137
outpatient	O
clinic	I:C0029916
.	O

This	O
study	O
evaluates	B:C0220825
the	O
potential	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
in	O
Turkish	O
elderly	O
patients	O
at	O
a	O
primary	O
health	I:C0033137
care	I:C0033137
outpatient	O
clinic	I:C0029916
.	O

This	O
study	O
evaluates	O
the	O
potential	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
in	O
Turkish	O
elderly	O
patients	O
at	O
a	O
primary	O
health	I:C0033137
care	I:C0033137
outpatient	O
clinic	I:C0029916
.	O

This	O
study	O
evaluates	O
the	O
potential	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
in	O
Turkish	O
elderly	B:C0001792
patients	O
at	O
a	O
primary	O
health	I:C0033137
care	I:C0033137
outpatient	O
clinic	I:C0029916
.	O

This	O
study	O
evaluates	O
the	O
potential	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
in	O
Turkish	O
elderly	O
patients	O
at	O
a	O
primary	B:C0033137
health	I:C0033137
care	I:C0033137
outpatient	O
clinic	I:C0029916
.	O

This	O
study	O
evaluates	O
the	O
potential	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
in	O
Turkish	O
elderly	O
patients	O
at	O
a	O
primary	O
health	I:C0033137
care	I:C0033137
outpatient	B:C0029916
clinic	I:C0029916
.	O

Online	B:C0242356
database	I:C0242356
systems	I:C0242356
were	O
used	O
to	O
examine	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
on	O
the	O
prescriptions	O
of	O
patients	O
(	O
n	O
=	O
1206	O
)	O
.	O

Online	O
database	I:C0242356
systems	I:C0242356
were	O
used	O
to	O
examine	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
on	O
the	O
prescriptions	O
of	O
patients	O
(	O
n	O
=	O
1206	O
)	O
.	O

Online	O
database	I:C0242356
systems	I:C0242356
were	O
used	O
to	O
examine	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
on	O
the	O
prescriptions	B:C0033080
of	O
patients	O
(	O
n	O
=	O
1206	O
)	O
.	O

The	O
clinical	B:C1836458
severity	I:C1836458
of	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
was	O
classified	O
by	O
the	O
Lexi-Interact	O
Online	I:C0242356
database	I:C0242356
.	O

The	O
clinical	O
severity	I:C1836458
of	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
was	O
classified	O
by	O
the	O
Lexi-Interact	O
Online	I:C0242356
database	I:C0242356
.	O

The	O
clinical	O
severity	I:C1836458
of	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
was	O
classified	O
by	O
the	O
Lexi-Interact	B:C0242356
Online	I:C0242356
database	I:C0242356
.	O

Of	O
the	O
5059	O
prescriptions	B:C0033080
,	O
33	O
%	O
were	O
found	O
to	O
have	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
.	O

Of	O
the	O
5059	O
prescriptions	O
,	O
33	O
%	O
were	O
found	O
to	O
have	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
.	O

We	O
detected	B:C0442726
29	O
(	O
0.9	O
%	O
)	O
A	O
,	O
380	O
(	O
11.8	O
%	O
)	O
B	O
,	O
2494	O
(	O
77.7	O
%	O
)	O
C	O
,	O
289	O
(	O
9	O
%	O
)	O
D	O
,	O
and	O
18	O
(	O
0.6	O
%	O
)	O
X	O
risk	O
rating	O
category	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
among	O
the	O
prescriptions	O
.	O

We	O
detected	O
29	O
(	O
0.9	O
%	O
)	O
A	O
,	O
380	O
(	O
11.8	O
%	O
)	O
B	O
,	O
2494	O
(	O
77.7	O
%	O
)	O
C	O
,	O
289	O
(	O
9	O
%	O
)	O
D	O
,	O
and	O
18	O
(	O
0.6	O
%	O
)	O
X	O
risk	O
rating	O
category	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
among	O
the	O
prescriptions	O
.	O

We	O
detected	O
29	O
(	O
0.9	O
%	O
)	O
A	O
,	O
380	O
(	O
11.8	O
%	O
)	O
B	O
,	O
2494	O
(	O
77.7	O
%	O
)	O
C	O
,	O
289	O
(	O
9	O
%	O
)	O
D	O
,	O
and	O
18	O
(	O
0.6	O
%	O
)	O
X	O
risk	O
rating	O
category	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
among	O
the	O
prescriptions	B:C0033080
.	O

Prescriptions	B:C0033080
of	O
female	O
patients	O
and	O
patients	O
aged	O
between	O
65	O
and	O
72	O
years	O
showed	O
significantly	O
higher	O
number	O
of	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
.	O

Prescriptions	O
of	O
female	O
patients	O
and	O
patients	O
aged	O
between	O
65	O
and	O
72	O
years	O
showed	O
significantly	O
higher	O
number	O
of	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
.	O

The	O
frequency	O
of	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
increased	O
both	O
with	O
the	O
number	O
of	O
drugs	O
and	O
combined	O
preparations	O
per	O
prescription	O
.	O

The	O
frequency	O
of	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
increased	O
both	O
with	O
the	O
number	O
of	O
drugs	B:C1254351
and	O
combined	O
preparations	O
per	O
prescription	O
.	O

The	O
frequency	O
of	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
increased	O
both	O
with	O
the	O
number	O
of	O
drugs	O
and	O
combined	O
preparations	O
per	O
prescription	B:C0033080
.	O

Acetylsalicylic	B:C0004057
acid	I:C0004057
and	O
salbutamol	O
were	O
the	O
most	O
frequently	O
prescribed	O
drugs	O
contributing	O
to	O
clinically	O
important	I:C0243095
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
.	O

Acetylsalicylic	O
acid	I:C0004057
and	O
salbutamol	B:C0001927
were	O
the	O
most	O
frequently	O
prescribed	O
drugs	O
contributing	O
to	O
clinically	O
important	I:C0243095
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
.	O

Acetylsalicylic	O
acid	I:C0004057
and	O
salbutamol	O
were	O
the	O
most	O
frequently	O
prescribed	O
drugs	B:C1254351
contributing	O
to	O
clinically	O
important	I:C0243095
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
.	O

Acetylsalicylic	O
acid	I:C0004057
and	O
salbutamol	O
were	O
the	O
most	O
frequently	O
prescribed	O
drugs	O
contributing	O
to	O
clinically	B:C0243095
important	I:C0243095
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
.	O

Acetylsalicylic	O
acid	I:C0004057
and	O
salbutamol	O
were	O
the	O
most	O
frequently	O
prescribed	O
drugs	O
contributing	O
to	O
clinically	O
important	I:C0243095
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
.	O

Additionally	O
,	O
acetylsalicylic	B:C0004057
acid	I:C0004057
and	O
escitalopram	O
,	O
which	O
interact	O
with	O
each	O
other	O
,	O
were	O
found	O
on	O
the	O
list	O
of	O
Beers	O
criteria	O
.	O

Additionally	O
,	O
acetylsalicylic	O
acid	I:C0004057
and	O
escitalopram	B:C1099456
,	O
which	O
interact	O
with	O
each	O
other	O
,	O
were	O
found	O
on	O
the	O
list	O
of	O
Beers	O
criteria	O
.	O

The	O
most	O
predicted	B:C1333602
clinical	I:C1333602
outcomes	I:C1333602
of	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
were	O
increase	O
in	O
therapeutic	O
efficacy	O
and	O
adverse	O
/	O
toxic	O
reactions	I:C0542243
.	O

The	O
most	O
predicted	O
clinical	I:C1333602
outcomes	I:C1333602
of	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
were	O
increase	O
in	O
therapeutic	O
efficacy	O
and	O
adverse	O
/	O
toxic	O
reactions	I:C0542243
.	O

The	O
most	O
predicted	O
clinical	I:C1333602
outcomes	I:C1333602
of	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
were	O
increase	O
in	O
therapeutic	O
efficacy	O
and	O
adverse	B:C0559546
/	O
toxic	O
reactions	I:C0542243
.	O

The	O
most	O
predicted	O
clinical	I:C1333602
outcomes	I:C1333602
of	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
were	O
increase	O
in	O
therapeutic	O
efficacy	O
and	O
adverse	O
/	O
toxic	B:C0542243
reactions	I:C0542243
.	O

Conclusions	O
:	O
Prediction	O
of	O
drug	B:C0687133
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
in	O
elderly	O
patients	O
will	O
provide	O
better	O
prescribing	O
and	O
drug	O
safety	O
.	O

Conclusions	O
:	O
Prediction	O
of	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
in	O
elderly	B:C0001792
patients	O
will	O
provide	O
better	O
prescribing	O
and	O
drug	O
safety	O
.	O

Conclusions	O
:	O
Prediction	O
of	O
drug	O
-	I:C0687133
drug	I:C0687133
interactions	I:C0687133
in	O
elderly	O
patients	O
will	O
provide	O
better	O
prescribing	B:C0033080
and	O
drug	O
safety	O
.	O

Use	O
of	O
nonsteroidal	B:C0003211
anti-inflammatory	I:C0003211
agents	I:C0003211
,	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
,	O
and	O
beta	O
-	I:C2936789
2	I:C2936789
adrenergic	I:C2936789
receptor	I:C2936789
agonists	I:C2936789
should	O
be	O
closely	O
monitored	O
.	O

Use	O
of	O
nonsteroidal	O
anti-inflammatory	I:C0003211
agents	I:C0003211
,	O
selective	B:C0360105
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
,	O
and	O
beta	O
-	I:C2936789
2	I:C2936789
adrenergic	I:C2936789
receptor	I:C2936789
agonists	I:C2936789
should	O
be	O
closely	O
monitored	O
.	O

Use	O
of	O
nonsteroidal	O
anti-inflammatory	I:C0003211
agents	I:C0003211
,	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
,	O
and	O
beta	B:C2936789
-	I:C2936789
2	I:C2936789
adrenergic	I:C2936789
receptor	I:C2936789
agonists	I:C2936789
should	O
be	O
closely	O
monitored	O
.	O

